Power Law company profile

Ascentage Pharma

Biotech & Life Sciences · Rockville, United States · Founded 2009 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.96B

Market cap · Apr/2026

Revenue

$79M

Latest reported FY

Investors

6 investors on Ascentage Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

BioVenture Capital

Oriza Holdings

YuanMing Capital

Series B+ 3 investors entered at this stage

State Development & Investment Corporation (SDIC)

CCB International

ArrowMark Partners

Global footprint

Where Ascentage Pharma has talent and traffic

AI talent share

1.1% of workforce is AI talent
(2 of 181 staff)

Core AI00%

Other AI21.1%

Non-AI workforce17998.9%

Web traffic by country

4.1K monthly visits
across markets

🇺🇸 United States82.9%

🇮🇳 India17.1%

Top 2 markets shown

Patent intelligence

$66M patent portfolio · 146 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$66M

3.4% of market cap · comparable to top peer Innocare ($56M)

146 active patent families

Where Ascentage Pharma innovates CarcinosisPharmaceutical drugDiseasePharmaceutical medicineOncology

Above peer median on Legal

Quality vs same-sector peers

Ascentage Pharma on the five Patsnap quality dimensions

Ascentage Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Ascentage Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Ascentage Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Ascentage Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo